Acute 0 5 0 5 B-chronic_disease
ST 6 8 6 8 I-chronic_disease
elevation 9 18 9 18 I-chronic_disease
myocardial 19 29 19 29 I-chronic_disease
infarction 30 40 30 40 I-chronic_disease
, 40 41 40 41 O
and/or 42 48 42 48 O
acute 49 54 49 54 B-chronic_disease
decompensated 55 68 55 68 I-chronic_disease
heart 69 74 69 74 I-chronic_disease
failure 75 82 75 82 I-chronic_disease
, 82 83 82 83 O
and/or 84 90 84 90 O
QTc 91 94 91 94 B-clinical_variable
> 95 96 95 96 O
520 97 100 97 100 B-lower_bound
ms 101 103 101 103 I-lower_bound
, 103 104 103 104 O
and/or 105 111 105 111 O
known 112 117 112 117 O
history 118 125 118 125 O
of 126 128 126 128 O
cardiac 129 136 129 136 B-chronic_disease
arrest 137 143 137 143 I-chronic_disease
( 144 145 144 145 O
PEA 145 148 145 148 O
, 148 149 148 149 O
VT 150 152 150 152 O
, 152 153 152 153 O
VF 154 156 154 156 O
, 156 157 156 157 O
asystole 158 166 158 166 O
) 166 167 166 167 O
, 167 168 167 168 O
and/or 169 175 169 175 O
admission 176 185 176 185 O
for 186 189 186 189 O
an 190 192 190 192 O
acute 193 198 193 198 B-chronic_disease
coronary 199 207 199 207 I-chronic_disease
syndrome 208 216 208 216 I-chronic_disease
, 216 217 216 217 O
myocardial 218 228 218 228 O
infarction 229 239 229 239 O
, 239 240 239 240 O
or 241 243 241 243 O
coronary 244 252 244 252 B-treatment
intervention 253 265 253 265 I-treatment
( 266 267 266 267 O
percutaneous 267 279 267 279 B-treatment
coronary 280 288 280 288 I-treatment
intervention 289 301 289 301 I-treatment
or 302 304 302 304 O
coronary 305 313 305 313 B-treatment
artery 314 320 314 320 I-treatment
surgery 321 328 321 328 I-treatment
) 328 329 328 329 O
within 330 336 330 336 O
the 337 340 337 340 O
past 341 345 341 345 B-upper_bound
3 346 347 346 347 I-upper_bound
months 348 354 348 354 I-upper_bound

Acute 0 5 355 360 O
cervical 6 14 361 369 B-chronic_disease
SCI 15 18 370 373 I-chronic_disease
with 19 23 374 378 O
ASIA 24 28 379 383 B-clinical_variable
Impairment 29 39 384 394 I-clinical_variable
Scale 40 45 395 400 I-clinical_variable
grade 46 51 401 406 O
A 52 53 407 408 O
, 53 54 408 409 O
B 55 56 410 411 O
or 57 59 412 414 O
C 60 61 415 416 O
on 62 64 417 419 O
admission 65 74 420 429 O

Age 0 3 430 433 B-age
: 3 4 433 434 O
≥ 5 6 435 436 O
18 7 9 437 439 B-lower_bound
years 10 15 440 445 I-lower_bound
and 16 19 446 449 O
≤ 20 21 450 451 O
80 22 24 452 454 B-upper_bound
years 25 30 455 460 I-upper_bound

Any 0 3 461 464 O
condition 4 13 465 474 O
likely 14 20 475 481 O
to 21 23 482 484 O
result 24 30 485 491 O
in 31 33 492 494 O
the 34 37 495 498 O
patient 38 45 499 506 O
's 45 47 506 508 O
death 48 53 509 514 O
within 54 60 515 521 O
the 61 64 522 525 O
next 65 69 526 530 B-upper_bound
12 70 72 531 533 I-upper_bound
months 73 79 534 540 I-upper_bound

Blood 0 5 541 546 B-clinical_variable
glucose 6 13 547 554 I-clinical_variable
< 14 15 555 556 O
55 15 17 556 558 B-upper_bound
mg 18 20 559 561 I-upper_bound
/ 20 21 561 562 I-upper_bound
dL 21 23 562 564 I-upper_bound
at 24 26 565 567 O
enrollment 27 37 568 578 O
or 38 40 579 581 O
immediately 41 52 582 593 O
prior 53 58 594 599 O
to 59 61 600 602 O
administration 62 76 603 617 O
of 77 79 618 620 O
DiaBeta 80 87 621 628 B-treatment
, 87 88 628 629 O
or 89 91 630 632 O
a 92 93 633 634 O
clinically 94 104 635 645 O
significant 105 116 646 657 O
history 117 124 658 665 O
of 125 127 666 668 O
hypoglycemia 128 140 669 681 B-treatment

Breast 0 6 682 688 O
- 6 7 688 689 O
feeding 7 14 689 696 O
women 15 20 697 702 B-gender
who 21 24 703 706 O
do 25 27 707 709 O
not 28 31 710 713 O
agree 32 37 714 719 O
to 38 40 720 722 O
stop 41 45 723 727 O
breast 46 52 728 734 O
- 52 53 734 735 O
feeding 53 60 735 742 O
during 61 67 743 749 O
and 68 71 750 753 O
for 72 75 754 757 O
7 76 77 758 759 O
days 78 82 760 764 O
following 83 92 765 774 O
the 93 96 775 778 O
end 97 100 779 782 O
of 101 103 783 785 O
oral 104 108 786 790 B-treatment
glyburide 109 118 791 800 I-treatment
administration 119 133 801 815 O

Currently 0 9 816 825 O
involved 10 18 826 834 O
in 19 21 835 837 O
another 22 29 838 845 O
non 30 33 846 849 O
- 33 34 849 850 O
observational 34 47 850 863 O
SCI 48 51 864 867 O
research 52 60 868 876 O
study 61 66 877 882 O
or 67 69 883 885 O
receiving 70 79 886 895 O
another 80 87 896 903 O
investigational 88 103 904 919 B-treatment
drug 104 108 920 924 I-treatment

History 0 7 925 932 O
of 8 10 933 935 O
hypersensitivity 11 27 936 952 O
to 28 30 953 955 O
sulfonylureas 31 44 956 969 B-allergy_name
, 44 45 969 970 O
in 46 48 971 973 O
particular 49 59 974 984 O
glyburide 60 69 985 994 B-allergy_name
, 69 70 994 995 O
or 71 73 996 998 O
any 74 77 999 1002 O
of 78 80 1003 1005 O
its 81 84 1006 1009 O
components 85 95 1010 1020 O

Initiation 0 10 1021 1031 O
of 11 13 1032 1034 O
study 14 19 1035 1040 O
drug 20 24 1041 1045 O
within 25 31 1046 1052 O
8 32 33 1053 1054 B-upper_bound
hours 34 39 1055 1060 I-upper_bound
of 40 42 1061 1063 O
injury 43 49 1064 1070 O

Known 0 5 1071 1076 O
G6PD 6 10 1077 1081 B-chronic_disease
enzyme 11 17 1082 1088 I-chronic_disease
deficiency 18 28 1089 1099 I-chronic_disease

Known 0 5 1100 1105 O
treatment 6 15 1106 1115 O
with 16 20 1116 1120 O
Bosentan 21 29 1121 1129 B-treatment
within 30 36 1130 1136 O
past 37 41 1137 1141 B-upper_bound
7 42 43 1142 1143 I-upper_bound
days 44 48 1144 1148 I-upper_bound

No 0 2 1149 1151 O
evidence 3 11 1152 1160 O
of 12 14 1161 1163 O
sepsis 15 21 1164 1170 B-chronic_disease

Non 0 3 1171 1174 O
- 3 4 1174 1175 O
penetrating 4 15 1175 1186 O
SCI 16 19 1187 1190 B-chronic_disease
at 20 22 1191 1193 O
neurologic 23 33 1194 1204 B-clinical_variable
level 34 39 1205 1210 I-clinical_variable
from 40 44 1211 1215 O
C2 45 47 1216 1218 B-lower_bound
to 48 50 1219 1221 O
C8 51 53 1222 1224 B-upper_bound

Other 0 5 1225 1230 O
illness 6 13 1231 1238 O
( 14 15 1239 1240 O
including 15 24 1240 1249 O
mental 25 31 1250 1256 B-chronic_disease
disorder 32 40 1257 1265 I-chronic_disease
) 40 41 1265 1266 O
that 42 46 1267 1271 O
could 47 52 1272 1277 O
preclude 53 61 1278 1286 O
accurate 62 70 1287 1295 O
medical 71 78 1296 1303 O
and 79 82 1304 1307 O
neurological 83 95 1308 1320 O
evaluation 96 106 1321 1331 O
( 107 108 1332 1333 O
at 108 110 1333 1335 O
discretion 111 121 1336 1346 O
of 122 124 1347 1349 O
the 125 128 1350 1353 O
site 129 133 1354 1358 O
investigator 134 146 1359 1371 O
) 146 147 1371 1372 O

Pregnancy 0 9 1373 1382 B-pregnancy
: 9 10 1382 1383 O
Women 11 16 1384 1389 B-gender
must 17 21 1390 1394 O
be 22 24 1395 1397 O
either 25 31 1398 1404 O
post 32 36 1405 1409 O
- 36 37 1409 1410 O
menopausal 37 47 1410 1420 O
, 47 48 1420 1421 O
permanently 49 60 1422 1433 O
sterilized 61 71 1434 1444 O
or 72 74 1445 1447 O
, 74 75 1447 1448 O
if 76 78 1449 1451 O
≤ 79 80 1452 1453 O
50 81 83 1454 1456 B-upper_bound
years 84 89 1457 1462 I-upper_bound
old 90 93 1463 1466 O
, 93 94 1466 1467 O
must 95 99 1468 1472 O
have 100 104 1473 1477 O
a 105 106 1478 1479 O
negative 107 115 1480 1488 B-pregnancy
test 116 120 1489 1493 I-pregnancy
for 121 124 1494 1497 I-pregnancy
pregnancy 125 134 1498 1507 I-pregnancy
obtained 135 143 1508 1516 O
before 144 150 1517 1523 O
enrollment 151 161 1524 1534 O

Severe 0 6 1535 1541 B-chronic_disease
renal 7 12 1542 1547 I-chronic_disease
disorder 13 21 1548 1556 I-chronic_disease
from 22 26 1557 1561 O
the 27 30 1562 1565 O
patient 31 38 1566 1573 O
's 38 40 1573 1575 O
history 41 48 1576 1583 O
( 49 50 1584 1585 O
e.g. 50 54 1585 1589 O
dialysis 55 63 1590 1598 B-treatment
) 63 64 1598 1599 O
or 65 67 1600 1602 O
baseline 68 76 1603 1611 O
eGFR 77 81 1612 1616 B-clinical_variable
of 82 84 1617 1619 O
< 85 86 1620 1621 O
30 87 89 1622 1624 B-upper_bound
mL 90 92 1625 1627 I-upper_bound
/ 92 93 1627 1628 I-upper_bound
min/1.73 93 101 1628 1636 I-upper_bound
m2 102 104 1637 1639 I-upper_bound

Unconsciousness 0 15 1640 1655 O
or 16 18 1656 1658 O
other 19 24 1659 1664 O
mental 25 31 1665 1671 B-chronic_disease
impairment 32 42 1672 1682 I-chronic_disease
that 43 47 1683 1687 O
prevents 48 56 1688 1696 O
neurological 57 69 1697 1709 O
assessment 70 80 1710 1720 O
within 81 87 1721 1727 O
the 88 91 1728 1731 O
first 92 97 1732 1737 B-upper_bound
8 98 99 1738 1739 I-upper_bound
hours 100 105 1740 1745 I-upper_bound

